Patents by Inventor Christine í. DALI

Christine í. DALI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230226036
    Abstract: The present invention relates to an active pharmaceutical ingredient selected from N-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride, its stereoisomers and the acid addition salts thereof; specifically arimoclomol, for use in methods of treating Gaucher disease (GD).
    Type: Application
    Filed: June 24, 2021
    Publication date: July 20, 2023
    Inventors: Thomas Kirkegaard Jensen, Anders Mørkeberg Hinsby, Cathrine Kolster Fog-Tønnensen, Linda Ingemann, Christine í Dali
  • Publication number: 20220211687
    Abstract: This application is directed to assays, diagnostic methods and treatment methods using arimoclomol for the treatment of Niemann-Pick disease type C (NPC). More specifically, this application is directed to assays, diagnostics methods and treatment methods that target specific clinical subsets of patients with NPC who exhibit at least one missense mutation in at least one allele of an NPC gene.
    Type: Application
    Filed: December 23, 2021
    Publication date: July 7, 2022
    Inventors: Thomas Kirkegaard JENSEN, Christine í. DALI, Nikolaj Havnsøe Torp PETERSEN, Thomas BLAETTLER, Lærke Clement FREIBERG